IBDEI3AU ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.4,119,0)
;;=CHEMO NURSE PROCEDURES^2^22
;;^UTILITY(U,$J,358.4,120,0)
;;=INFUSION DRUGS^7^22
;;^UTILITY(U,$J,358.4,121,0)
;;=BLOOD PRODUCTS^1^22
;;^UTILITY(U,$J,358.4,122,0)
;;=DIAGNOSTIC PROCEDURES^3^22
;;^UTILITY(U,$J,358.4,123,0)
;;=OTHER DRUGS^8^22
;;^UTILITY(U,$J,358.4,124,0)
;;=IMMUNIZATION ADMINISTRATION^5^22
;;^UTILITY(U,$J,358.4,125,0)
;;=IMMUNIZATIONS^6^22
;;^UTILITY(U,$J,358.4,126,0)
;;=PROLONGED SVC-MD/NP/PA^9^22
;;^UTILITY(U,$J,358.4,127,0)
;;=EDUCATION/TRAINING^4^22
;;^UTILITY(U,$J,358.4,128,0)
;;=NEW PATIENT^2^23
;;^UTILITY(U,$J,358.4,129,0)
;;=ESTABLISHED PATIENT^1^23
;;^UTILITY(U,$J,358.4,130,0)
;;=CONSULTATIONS^3^23
;;^UTILITY(U,$J,358.4,131,0)
;;=COMPLEX CHRONIC CARE^4^23
;;^UTILITY(U,$J,358.4,132,0)
;;=ANEMIA^1^24
;;^UTILITY(U,$J,358.4,133,0)
;;=ARTIFICIAL OPENING STATUS^2^24
;;^UTILITY(U,$J,358.4,134,0)
;;=BREASTS and GYN NEOPLASMS^3^24
;;^UTILITY(U,$J,358.4,135,0)
;;=COAGULATION DISORDERS^4^24
;;^UTILITY(U,$J,358.4,136,0)
;;=COUNSELING AND SCREENING^5^24
;;^UTILITY(U,$J,358.4,137,0)
;;=GENITOURINARY NEOPLASMS^6^24
;;^UTILITY(U,$J,358.4,138,0)
;;=GI CANCER^7^24
;;^UTILITY(U,$J,358.4,139,0)
;;=HEAD NECK AND LUNGS NEOPLASMS^8^24
;;^UTILITY(U,$J,358.4,140,0)
;;=HEMOGLOBINOPATHIES^9^24
;;^UTILITY(U,$J,358.4,141,0)
;;=LYMPHOID NEOPLASMS^10^24
;;^UTILITY(U,$J,358.4,142,0)
;;=METASTATIC SITES^13^24
;;^UTILITY(U,$J,358.4,143,0)
;;=MALIGNANT NEOPLASMS OF OTHER SITES^11^24
;;^UTILITY(U,$J,358.4,144,0)
;;=MYELOID NEOPLASMS AND DISORDERS^14^24
;;^UTILITY(U,$J,358.4,145,0)
;;=NEOPLASM OF UNCERTAIN BEHAVIOR^15^24
;;^UTILITY(U,$J,358.4,146,0)
;;=NEOPLASM OF UNSPECIFIED NATURE^16^24
;;^UTILITY(U,$J,358.4,147,0)
;;=PERSONAL HISTORY^19^24
;;^UTILITY(U,$J,358.4,148,0)
;;=MALNUTRITION^12^24
;;^UTILITY(U,$J,358.4,149,0)
;;=OTHER^18^24
;;^UTILITY(U,$J,358.4,150,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^20^24
;;^UTILITY(U,$J,358.4,151,0)
;;=CHEST WALL AND NECK^1^25
;;^UTILITY(U,$J,358.4,152,0)
;;=THORACIC^2^25
;;^UTILITY(U,$J,358.4,153,0)
;;=OTHER PROCEDURES^3^25
;;^UTILITY(U,$J,358.4,154,0)
;;=NEW PATIENT^2^26
;;^UTILITY(U,$J,358.4,155,0)
;;=ESTABLISHED PATIENT^1^26
;;^UTILITY(U,$J,358.4,156,0)
;;=CONSULTATIONS^3^26
;;^UTILITY(U,$J,358.4,157,0)
;;=POST-OP FOLLOW-UP^4^26
;;^UTILITY(U,$J,358.4,158,0)
;;=GENERAL SIGNS & SYMPTOMS^3^27
;;^UTILITY(U,$J,358.4,159,0)
;;=AFTERCARE POST-OP^1^27
;;^UTILITY(U,$J,358.4,160,0)
;;=POST-OP COMPLICATIONS^5^27
;;^UTILITY(U,$J,358.4,161,0)
;;=CARDIOVASCULAR^2^27
;;^UTILITY(U,$J,358.4,162,0)
;;=RESPIRATORY^7^27
;;^UTILITY(U,$J,358.4,163,0)
;;=NEOPLASM^4^27
;;^UTILITY(U,$J,358.4,164,0)
;;=PRE-OP^6^27
;;^UTILITY(U,$J,358.4,165,0)
;;=SUICIDE IDEATION/ATTEMPTS^8^27
;;^UTILITY(U,$J,358.4,166,0)
;;=ESTABLISHED PATIENT^1^28
;;^UTILITY(U,$J,358.4,167,0)
;;=CONSULTATIONS/OPINIONS^2^28
;;^UTILITY(U,$J,358.4,168,0)
;;=NEW PATIENTS^3^28
;;^UTILITY(U,$J,358.4,169,0)
;;=NEUROLOGY/SEIZURE^7^29
;;^UTILITY(U,$J,358.4,170,0)
;;=EEG^4^29
;;^UTILITY(U,$J,358.4,171,0)
;;=SLEEP TESTING^9^29
;;^UTILITY(U,$J,358.4,172,0)
;;=MUSCLE TESTING/EMG^6^29
;;^UTILITY(U,$J,358.4,173,0)
;;=EVOKED POTENTIAL^5^29
;;^UTILITY(U,$J,358.4,174,0)
;;=BIOPSY^2^29
;;^UTILITY(U,$J,358.4,175,0)
;;=AUTONOMIC FUNCTION TESTS^1^29
;;^UTILITY(U,$J,358.4,176,0)
;;=STEREOTACTIC^10^29
;;^UTILITY(U,$J,358.4,177,0)
;;=EDUCATION^3^29
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3AU 3768 printed Sep 23, 2025@20:21:13 Page 2
IBDEI3AU ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.4)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.4,119,0)
+2 ;;=CHEMO NURSE PROCEDURES^2^22
+3 ;;^UTILITY(U,$J,358.4,120,0)
+4 ;;=INFUSION DRUGS^7^22
+5 ;;^UTILITY(U,$J,358.4,121,0)
+6 ;;=BLOOD PRODUCTS^1^22
+7 ;;^UTILITY(U,$J,358.4,122,0)
+8 ;;=DIAGNOSTIC PROCEDURES^3^22
+9 ;;^UTILITY(U,$J,358.4,123,0)
+10 ;;=OTHER DRUGS^8^22
+11 ;;^UTILITY(U,$J,358.4,124,0)
+12 ;;=IMMUNIZATION ADMINISTRATION^5^22
+13 ;;^UTILITY(U,$J,358.4,125,0)
+14 ;;=IMMUNIZATIONS^6^22
+15 ;;^UTILITY(U,$J,358.4,126,0)
+16 ;;=PROLONGED SVC-MD/NP/PA^9^22
+17 ;;^UTILITY(U,$J,358.4,127,0)
+18 ;;=EDUCATION/TRAINING^4^22
+19 ;;^UTILITY(U,$J,358.4,128,0)
+20 ;;=NEW PATIENT^2^23
+21 ;;^UTILITY(U,$J,358.4,129,0)
+22 ;;=ESTABLISHED PATIENT^1^23
+23 ;;^UTILITY(U,$J,358.4,130,0)
+24 ;;=CONSULTATIONS^3^23
+25 ;;^UTILITY(U,$J,358.4,131,0)
+26 ;;=COMPLEX CHRONIC CARE^4^23
+27 ;;^UTILITY(U,$J,358.4,132,0)
+28 ;;=ANEMIA^1^24
+29 ;;^UTILITY(U,$J,358.4,133,0)
+30 ;;=ARTIFICIAL OPENING STATUS^2^24
+31 ;;^UTILITY(U,$J,358.4,134,0)
+32 ;;=BREASTS and GYN NEOPLASMS^3^24
+33 ;;^UTILITY(U,$J,358.4,135,0)
+34 ;;=COAGULATION DISORDERS^4^24
+35 ;;^UTILITY(U,$J,358.4,136,0)
+36 ;;=COUNSELING AND SCREENING^5^24
+37 ;;^UTILITY(U,$J,358.4,137,0)
+38 ;;=GENITOURINARY NEOPLASMS^6^24
+39 ;;^UTILITY(U,$J,358.4,138,0)
+40 ;;=GI CANCER^7^24
+41 ;;^UTILITY(U,$J,358.4,139,0)
+42 ;;=HEAD NECK AND LUNGS NEOPLASMS^8^24
+43 ;;^UTILITY(U,$J,358.4,140,0)
+44 ;;=HEMOGLOBINOPATHIES^9^24
+45 ;;^UTILITY(U,$J,358.4,141,0)
+46 ;;=LYMPHOID NEOPLASMS^10^24
+47 ;;^UTILITY(U,$J,358.4,142,0)
+48 ;;=METASTATIC SITES^13^24
+49 ;;^UTILITY(U,$J,358.4,143,0)
+50 ;;=MALIGNANT NEOPLASMS OF OTHER SITES^11^24
+51 ;;^UTILITY(U,$J,358.4,144,0)
+52 ;;=MYELOID NEOPLASMS AND DISORDERS^14^24
+53 ;;^UTILITY(U,$J,358.4,145,0)
+54 ;;=NEOPLASM OF UNCERTAIN BEHAVIOR^15^24
+55 ;;^UTILITY(U,$J,358.4,146,0)
+56 ;;=NEOPLASM OF UNSPECIFIED NATURE^16^24
+57 ;;^UTILITY(U,$J,358.4,147,0)
+58 ;;=PERSONAL HISTORY^19^24
+59 ;;^UTILITY(U,$J,358.4,148,0)
+60 ;;=MALNUTRITION^12^24
+61 ;;^UTILITY(U,$J,358.4,149,0)
+62 ;;=OTHER^18^24
+63 ;;^UTILITY(U,$J,358.4,150,0)
+64 ;;=SUICIDE IDEATIONS/ATTEMPTS^20^24
+65 ;;^UTILITY(U,$J,358.4,151,0)
+66 ;;=CHEST WALL AND NECK^1^25
+67 ;;^UTILITY(U,$J,358.4,152,0)
+68 ;;=THORACIC^2^25
+69 ;;^UTILITY(U,$J,358.4,153,0)
+70 ;;=OTHER PROCEDURES^3^25
+71 ;;^UTILITY(U,$J,358.4,154,0)
+72 ;;=NEW PATIENT^2^26
+73 ;;^UTILITY(U,$J,358.4,155,0)
+74 ;;=ESTABLISHED PATIENT^1^26
+75 ;;^UTILITY(U,$J,358.4,156,0)
+76 ;;=CONSULTATIONS^3^26
+77 ;;^UTILITY(U,$J,358.4,157,0)
+78 ;;=POST-OP FOLLOW-UP^4^26
+79 ;;^UTILITY(U,$J,358.4,158,0)
+80 ;;=GENERAL SIGNS & SYMPTOMS^3^27
+81 ;;^UTILITY(U,$J,358.4,159,0)
+82 ;;=AFTERCARE POST-OP^1^27
+83 ;;^UTILITY(U,$J,358.4,160,0)
+84 ;;=POST-OP COMPLICATIONS^5^27
+85 ;;^UTILITY(U,$J,358.4,161,0)
+86 ;;=CARDIOVASCULAR^2^27
+87 ;;^UTILITY(U,$J,358.4,162,0)
+88 ;;=RESPIRATORY^7^27
+89 ;;^UTILITY(U,$J,358.4,163,0)
+90 ;;=NEOPLASM^4^27
+91 ;;^UTILITY(U,$J,358.4,164,0)
+92 ;;=PRE-OP^6^27
+93 ;;^UTILITY(U,$J,358.4,165,0)
+94 ;;=SUICIDE IDEATION/ATTEMPTS^8^27
+95 ;;^UTILITY(U,$J,358.4,166,0)
+96 ;;=ESTABLISHED PATIENT^1^28
+97 ;;^UTILITY(U,$J,358.4,167,0)
+98 ;;=CONSULTATIONS/OPINIONS^2^28
+99 ;;^UTILITY(U,$J,358.4,168,0)
+100 ;;=NEW PATIENTS^3^28
+101 ;;^UTILITY(U,$J,358.4,169,0)
+102 ;;=NEUROLOGY/SEIZURE^7^29
+103 ;;^UTILITY(U,$J,358.4,170,0)
+104 ;;=EEG^4^29
+105 ;;^UTILITY(U,$J,358.4,171,0)
+106 ;;=SLEEP TESTING^9^29
+107 ;;^UTILITY(U,$J,358.4,172,0)
+108 ;;=MUSCLE TESTING/EMG^6^29
+109 ;;^UTILITY(U,$J,358.4,173,0)
+110 ;;=EVOKED POTENTIAL^5^29
+111 ;;^UTILITY(U,$J,358.4,174,0)
+112 ;;=BIOPSY^2^29
+113 ;;^UTILITY(U,$J,358.4,175,0)
+114 ;;=AUTONOMIC FUNCTION TESTS^1^29
+115 ;;^UTILITY(U,$J,358.4,176,0)
+116 ;;=STEREOTACTIC^10^29
+117 ;;^UTILITY(U,$J,358.4,177,0)
+118 ;;=EDUCATION^3^29
